REGAN CLYMER: Open Payments
NPI 1871032532 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$145 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $67 · 2025 $145
Food & beverage: $145
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $42 |
| Lilly USA, LLC | 1 | $30 |
| ABBVIE INC. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Celltrion USA Inc. | 1 | $23 |
Products named: TREMFYA, OMVOH, SKYRIZI, ENTYVIO, VEGZELMA.
Industry payments across NE — which companies pay providers there.
